ArticleOncotarget2014

Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR / SphK1 crosstalk.

Carlotta Schiefler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.